9.6 Percent of Medical Visits Took Place Via Telehealth in 2021
Percentage of telehealth visits was higher for mental health than other clinicians
First-Line Biparametric MRI Less Cost-Effective Than PSA for Prostate Cancer Screening
First-line PSA screening remained cost-effective even if bpMRI was free and all men with low-risk prostate cancer underwent surveillance
Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer
At 10 years after diagnosis, estimated rates of metastasis and prostate cancer-related death were 1.4 and 0.1 percent
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending
From 2007 to 2019, medical burden increased from 23.5 to 26.4 percent for low-income families and from 5.4 to 6.5 percent for higher-income families
AACR Delivers Report on Disparities in Cancer Progress
Black and Indigenous individuals have higher overall cancer death rates, despite having lower cancer incidence rates
Physicians With Disabilities May Experience Depersonalization
However, they are not more likely to experience emotional exhaustion
Cyberattack Cripples Major U.S. Health Care Network
Biomarkers + Patient-Reported Outcomes Up Prediction of Interstitial Cystitis
Area under the curve higher for biomarker measurements and patient-reported outcomes versus outcomes or biomarkers alone
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
FDA Approves New Antibiotic for Uncomplicated Urinary Tract Infections
Approval of Pivya is for female adults with UTIs caused by susceptible isolates of E. coli, P. mirabilis, and S. saprophyticus
